Studies in mice and humans suggest that cellular senescence, the cessation of cell proliferation that is known to suppress cancer and promote ageing, may have evolved to regulate embryonic development.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Campisi, J. & d'Adda di Fagagna, F. Nature Rev. Mol. Cell Biol. 8, 729–740 (2007).
Collado, M. & Serrano, M. Nature Rev. Cancer 10, 51–57 (2010).
Cevenini, E., Monti, D. & Franceschi, C. Curr. Opin. Clin. Nutr. Metab. Care 16, 14–20 (2013).
Rodier, F. & Campisi, J. J. Cell Biol. 192, 547–556 (2011).
Muñoz-Espín, D. et al. Cell 155, 1104–1118 (2013).
Storer, M. et al. Cell 155, 1119–1130 (2013).
Martin, G. M. J. Gerontol. 48, B171–B172 (1993).
Coppé, J.-P. et al. PLoS Biol. 6, e301 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Campisi, J. The beginning of the end. Nature 505, 35–36 (2014). https://doi.org/10.1038/nature12844
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12844
Further reading
-
Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
Cell & Bioscience (2020)
-
Correction
Nature (2014)
-
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Protein & Cell (2014)